There were a few prostate cancer stories this week. Firstly, men with prostate cancer may not be receiving the care they need after treatment. For more info take a look at the press release .
And the Daily Mail covered two stories. The first reports that black men are at greater risk of developing prostate cancer than white men over their lifetime.
And they also covered the NHS approval of a new prostate cancer drug called enzalutamide.
Could the way we define cancer be changing? Our blog post explores how a global research effort is answering this question.
And CNET covered some of the latest results from this cross-continental project.
This interesting blog post from the Institute of Cancer Research explained how thalidomide may help patients with myeloma.
The Conversation gave this interesting take on an evolutionary theory of cancer.
Tuesday was Ada Lovelace Day – a celebration of women in science, technology, engineering and maths. The Guardian had details of the day’s events, including a wikipedia edit-a-thon.
Episode three of our Cancer Marathon series launched this week. Follow the journey over on our YouTube channel.
Headlines like those in The Express that state ‘cabbages can save lives’ should be taken with a pinch of salt. The researchers worked with a purified chemical found in cruciferous veg using animal models. It’s too early to tell if this will protect people from radiation therapy used to treat cancer.